Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis.
Zero Point Five Therapeutics has raised $4.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2025.
Zero Point Five Therapeutics's investors include Portfolia.
Zero Point Five Therapeutics is headquartered in Potomac, United States.
Zero Point Five Therapeutics develops drugs to treat soil-transmitted helminthiasis.
Zero Point Five Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zero Point Five Therapeutics — Funding & Investors." VCBacked, April 17, 2025, https://www.vcbacked.co/company/zero-point-five-therapeutics. Accessed November 13, 2026.
VCBacked. (2025). Zero Point Five Therapeutics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/zero-point-five-therapeutics
{{cite web |title=Zero Point Five Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/zero-point-five-therapeutics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Zero Point Five Therapeutics? Request a listing update